Lung Cancer Screening Implementation Among Employees at Lyon Hospital
NCT ID: NCT05452200
Last Updated: 2023-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
600 participants
INTERVENTIONAL
2022-09-21
2024-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In France, the participation rate for breast and colon cancer screening programs is respectively 50% and 32%, which is low. Then, it appears very important to determine which factors are influencing the willingness to participate to these programs. Indeed, it will allow a better communication and we will be able to perform screening campaigns adapted to the eligible population.
The Lyon Hospital is the second university hospital in France. It is composed of 14 buildings and employed 23 000 persons. More than 160 occupations are represented. So, hospital employees look relevant to be studied for LCS program.
ILYAD was divided in 2 parts. The first one was completed in 2020 and goal to evaluate the number of eligible individuals among the hospital employees. About 800 persons would be eligible for LCS.
This second part of the study will evaluate the participation rate and the feasibility of the LCS program. The study will target the 800 individuals that were identified previously.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Initiative in LYon for Lung cAncer Screening Development - Prevalence Study
NCT04240418
Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study
NCT06909981
Assessment of Tobacco Smoking and Alcohol Drinking and Treatment Outcomes Among Patients With Lung or Head and Neck Cancer
NCT05523583
Using Connected Health to Increase Lung Cancer Screening
NCT04612946
Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.
NCT06020443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lyon hospital employees with high risk of lung cancer.
Lyon Hospital employees meeting criteria for high risk of lung cancer according French recommendation criteria.
Solicitation for lung cancer screening
3 levels of solicitation will be cumulated. First : a Simple collective solicitation of all staff via internal media 4 months later : Personalized indirect solicitation of at-risk groups with information posted in identified areas 4 months later : Personalized direct solicitation of at-risk groups
added exams to the usual lung cancer screening
* spirometry examination
* Questionnaires
* Blood samples and breath samples to find biomarkers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Solicitation for lung cancer screening
3 levels of solicitation will be cumulated. First : a Simple collective solicitation of all staff via internal media 4 months later : Personalized indirect solicitation of at-risk groups with information posted in identified areas 4 months later : Personalized direct solicitation of at-risk groups
added exams to the usual lung cancer screening
* spirometry examination
* Questionnaires
* Blood samples and breath samples to find biomarkers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Lyon hospital employee at the day of inclusion:
* valid hospital employee number,
* Or retired employee for less than a year before the inclusion
AND meeting eligibility criteria as follow :
* Aged from 50 to 75 yo,
* AND smoke or have smoked ≥ 10 cigarettes/day during ≥ 30 years OR ≥ 15 cigarettes/day for at least 25 years;
* AND active smoker or smoking cessation for ≤ 15 years ;
* Volunteer to start a program of smoking cessation if active smoker;
* Consent form signed ;
* Cover by health insurance.
Exclusion Criteria
* Individual not working at Lyon hospital;
* Individual not payed by the Lyon Hospital but working at it;
* Individuals not willing to participate;
* Individual working at René Sabran Hospital;
* Individual meeting one of this non eligibility for LCS criteria defined by the French recommendation:
* Not able to climb 2 floors of stairs ;
* Weight ≥ 140Kg
* Underwent a chest CT scan less than 1 year ago (except screening scanner);
* History of lung cancer of less than 5 years or under treatment ; history of any cancer under monitoring by chest scanner ;
* Comorbidity contraindicating therapeutic options or any kind of invasive interventions ;
* Ongoing or recent respiratory symptoms that might lead to lung cancer diagnosis (hemoptysia, weight loss, recurrent respiratory infection).
* Individual who is pregnant or breast feeding;
* Individual whose mental health is not good enough to participate;
* Individual in jail or under justice evaluation.
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital L. Pradel
Bron, , France
Hôpital de la Croix Rousse - Department of Pneumology
Lyon, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Michael DURUISSEAUX, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL22_0466
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.